Immediate Impact
2 from Science/Nature 71 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of David D. W. Twa being referenced
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David D. W. Twa | 262 | 278 | 62 | 154 | 13 | 470 | |
| C A Angel | 199 | 208 | 69 | 64 | 19 | 468 | |
| Jane O'Grady | 378 | 422 | 37 | 128 | 9 | 564 | |
| Limei Poon | 321 | 345 | 40 | 251 | 22 | 523 | |
| Laura Bellio | 99 | 184 | 52 | 141 | 15 | 495 | |
| R Pearce | 368 | 309 | 56 | 91 | 9 | 566 | |
| Shigeo Nakamura | 245 | 212 | 21 | 71 | 12 | 426 | |
| William G. Swartz | 259 | 165 | 43 | 122 | 12 | 457 | |
| Rien H. J. Van Oers | 204 | 169 | 19 | 183 | 12 | 490 | |
| D D Weisenburger | 214 | 192 | 37 | 73 | 16 | 443 | |
| Eve‐Marie Neidhardt‐Berard | 169 | 245 | 38 | 95 | 11 | 479 |
All Works
Login with ORCID to disown or claim papers
Loading papers...